|
ZNF436 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.890970E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.117500E-02 |
| Normal-vs-Stage2 |
6.908200E-01 |
| Normal-vs-Stage3 |
3.642600E-01 |
| Normal-vs-Stage4 |
8.147000E-01 |
| Stage1-vs-Stage2 |
1.332240E-01 |
| Stage1-vs-Stage3 |
8.548200E-01 |
| Stage1-vs-Stage4 |
2.808000E-01 |
| Stage2-vs-Stage3 |
2.795400E-01 |
| Stage2-vs-Stage4 |
5.977800E-01 |
| Stage3-vs-Stage4 |
5.224600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.883390E-01 |
| Normal-vs-AfricanAmerican |
9.697400E-01 |
| Normal-vs-Asian |
3.215900E-02 |
| Caucasian-vs-AfricanAmerican |
4.988200E-01 |
| Caucasian-vs-Asian |
1.007960E-01 |
| AfricanAmerican-vs-Asian |
7.957700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.594200E-01 |
| Normal-vs-Female |
2.330400E-01 |
| Male-vs-Female |
8.534600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.388600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.293600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.878970E-01 |
| Normal-vs-Age(81-100Yrs) |
3.879700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.984200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.110000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.939900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.326600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.776100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.281880E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.952000E-02 |
| Normal-vs-Grade 2 |
1.103640E-02 |
| Normal-vs-Grade 3 |
9.244200E-01 |
| Normal-vs-Grade 4 |
3.266400E-01 |
| Grade 1-vs-Grade 2 |
5.423400E-01 |
| Grade 1-vs-Grade 3 |
1.137610E-01 |
| Grade 1-vs-Grade 4 |
1.105840E-02 |
| Grade 2-vs-Grade 3 |
1.798420E-02 |
| Grade 2-vs-Grade 4 |
1.461800E-03 |
| Grade 3-vs-Grade 4 |
2.996400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.364590E-01 |
| Normal-vs-ccB subtype |
1.040770E-01 |
| ccA subtype-vs-ccB subtype |
5.524400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.362800E-01 |
| Normal-vs-N1 |
9.527000E-01 |
| N0-vs-N1 |
7.020400E-01 |
|
|
